- PTC to receive $1.0B in cash at closing - - PTC is eligible to receive up to $1.9B in development, regulatory and sales milestones - - PTC to share profits in the U.S. and tiered double-digit ...
(RTTNews) - Biopharmaceutical company PTC Therapeutics, Inc. (PTCT) announced Monday the signing of an exclusive global license and collaboration agreement with Novartis Pharmaceuticals Corp., a ...
PTC Therapeutics, a rare-disease drug company best known for small-molecule therapies that alter gene expression, is partnering with Odylia Therapeutics to develop gene therapies for inherited eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback